Replies to post #57409 on THE PARADIGM SHIFT

[charthawk]

CTIC, halted, and has nice news

Cell Therapeutics: Could Get Approval Decision From FDA In 4Q09

Pixantrone Significantly Increases Complete Remissions, Overall Response Rates, Frequency of Durable Remissions and Progression Free Survival in Patients with Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
Last update: 6/1/2009 2:00:00 PM